Varia Ventures

MimiVax, LLC is a clinical-stage biotechnology company based in Buffalo, New York, focused on developing immunotherapeutic vaccines and targeted therapies for cancer treatment. Founded in 2011, the company specializes in creating vaccines that utilize survivin-targeting technology, which aims to disrupt a cell-survival protein commonly found in various cancers. Its lead product, SurVaxM, is a peptide mimic immunotherapeutic vaccine designed to control tumor growth and recurrence, enhancing the potential for patient survival. Through its innovative approach, MimiVax seeks to provide healthcare providers with effective tools to improve cancer treatment outcomes.

Buffalo Automation Group, Inc., established in 2014 and based in East Amherst, New York, specializes in developing automated self-navigation technology for ships, waterways, and recreational boats. The company's flagship product, AutoMate, equips existing boats with a forward-facing camera for obstacle detection, enabling boaters to input destinations and receive real-time weather updates. Additionally, AutoMate offers situational awareness, decision support, remote monitoring, data analytics, and cloud-based fleet management platforms, enhancing safety and efficiency in marine navigation.